Providence Cancer center is focused on delivering state-of-the-art care to all patients with cancer while the Robert W. Franz Cancer Research Center in the Earle A. Chiles Research Institute is making the discoveries that will become treatments for future patients.
Improving patient care is the number one priority of “translational research.” Researchers take novel discoveries in the lab and collaborate with physician researchers to develop new treatments that can directly help people with cancer. This collaboration between scientists and physicians increases the number of treatment options that are available to patients. Additionally, by directly involving patients and physicians in their research, Providence scientists continually generate new ideas that pave the way to future discoveries.
Through Providence Cancer Center, patients have access to dozens of clinical trials of promising new drugs and cancer therapies developed by researchers at the Franz Cancer Research Center and other major cancer research institutions. Patients also have access to a broad range of clinical trials sponsored by pharmaceutical complanies. All programs are staffed by teams of physicians, nurses and other cancer specialists with up-to-the-minute knowledge of the latest treatment options for a variety of cancers. If a new treatment proves more effective than the standard treatment, then those patients who participated in the clinical trial may be among the first to benefit.
By working in close proximity to patients and to each other, Providence researchers, physicians and clinical trials staff create a synergy that enhances both research and patient care. That collaboration will be further enhanced by the opening of a new 11-story building on the Providence Portland Medical Center that expands and consolidates research and patient care under one roof in February 2008.
Providence Cancer center is focused on delivering state-of-the-art care to all patients with cancer while the Robert W. Franz Cancer Research Center in the Earle A. Chiles Research Institute is making the discoveries that will become treatments for future patients.